Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis.
暂无分享,去创建一个
Peter G. Smith | J. Ellner | M. Joloba | B. Kirenga | K. Eisenach | A. Elliott | R. Mugerwa | A. Okwera | Soyeon Kim | S. Dryden-Peterson | I. Ayakaka | E. Jones-López | K. Fennelly | Nancy Reilly | Christopher Muchwa | Harriet Menyha | A. Elliott
[1] F. Tenover. Developing molecular amplification methods for rapid diagnosis of respiratory tract infections caused by bacterial pathogens. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] Ruth McNerney,et al. Effectiveness of the Standard WHO Recommended Retreatment Regimen (Category II) for Tuberculosis in Kampala, Uganda: A Prospective Cohort Study , 2011, PLoS medicine.
[3] Z. Ristovski,et al. Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis , 2009, Thorax.
[4] B. Alisjahbana,et al. Insufficient quality of sputum submitted for tuberculosis diagnosis and associated factors, in Klaten district, Indonesia , 2009, BMC pulmonary medicine.
[5] A. R. Escombe,et al. The Infectiousness of Tuberculosis Patients Coinfected with HIV , 2008, PLoS medicine.
[6] L. Tanoue. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa , 2008 .
[7] S. Basu,et al. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study , 2007, The Lancet.
[8] K. Fennelly. Variability of airborne transmission of Mycobacterium tuberculosis: implications for control of tuberculosis in the HIV era. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] L. Lambert,et al. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[10] J. Hankinson,et al. Interpretative strategies for lung function tests , 2005, European Respiratory Journal.
[11] M. King,et al. A new paradigm in respiratory hygiene: increasing the cohesivity of airway secretions to improve cough interaction and reduce aerosol dispersion , 2005, BMC pulmonary medicine.
[12] M. Molyneux,et al. A Community-Based Study of the Incidence of Trimethoprim-Sulfamethoxazole-Preventable Infections in Malawian Adults Living With HIV , 2005, Journal of acquired immune deficiency syndromes.
[13] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[14] V. Cook,et al. Risk of tuberculosis in children from smear-negative source cases. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[15] W A Black,et al. Transmission of tuberculosis from smear negative patients: a molecular epidemiology study , 2004, Thorax.
[16] I. Orme,et al. Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness. , 2004, American journal of respiratory and critical care medicine.
[17] Christopher Dye,et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.
[18] D. Minnikin,et al. Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum. , 2002, Microbiology.
[19] N. Nagelkerke,et al. Transmission of Mycobacterium tuberculosis depending on the age and sex of source cases. , 2001, American journal of epidemiology.
[20] M. Behr,et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli , 1999, The Lancet.
[21] R. Urbanczik,et al. The public health service national tuberculosis reference laboratory and the national laboratory network : minimum requirements, role and operation in a low-income country , 1998 .
[22] D. Menzies. Effect of Treatment on Contagiousness of Patients With Active Pulmonary Tuberculosis , 1997, Infection Control & Hospital Epidemiology.
[23] C. Dye,et al. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] G. Schoolnik,et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. , 1994, The New England journal of medicine.
[25] D Alland,et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. , 1994, The New England journal of medicine.
[26] T. Frieden,et al. Tuberculosis transmission in the 1990s. , 1994, The New England journal of medicine.
[27] L. Clancy,et al. The pathogenicity of Mycobacterium tuberculosis during chemotherapy. , 1990, The European respiratory journal.
[28] D. Snider,et al. Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. , 2015, The American review of respiratory disease.
[29] Cassidy Jt. Tubercle bacilli retain pathogenicity after seven weeks chemotherapy. , 1981 .
[30] J. Cassidy. TUBERCLE BACILLI RETAIN PATHOGENICITY AFTER SEVEN WEEKS CHEMOTHERAPY , 1981, The Medical journal of Australia.
[31] R. Noble. Infectiousness of pulmonary tuberculosis after starting chemotherapy , 1981 .
[32] A. Rouillon,et al. Transmission of tubercle bacilli: The effects of chemotherapy. , 1976, Tubercle.
[33] K. Stýblo,et al. Results of contact examination in Rotterdam, 1967-1969. , 1975, Bulletin of the International Union against Tuberculosis.
[34] W. Stead,et al. Editorial: Effect of chemotherapy on infectiousness of tuberculosis. , 1974, The New England journal of medicine.
[35] S. Brooks,et al. A pilot study concerning the infection risk of sputum positive tuberculosis patients on chemotherapy. , 2015, The American review of respiratory disease.
[36] R. Riley,et al. Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients. , 1962, The American review of respiratory disease.
[37] R. Riley,et al. Tuberculosis disseminators. A study of the variability of aerial infectivity of tuberculous patients. , 1960, The American review of respiratory disease.
[38] William Firth Wells,et al. Airborne Contagion and Air Hygiene , 1955 .
[39] R. Glover. Infection of Mice with Mycobact. tuberculosis (Bovis) by the Respiratory Route , 1944 .